This topic contains 1 reply, has 2 voices, and was last updated by  rohit.kamble 7 months, 2 weeks ago.

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
  • #4036


    Causes Of Low Sperm Motility – Androferti is clinically proven to help support the overall male reproductive health and sperm quality. For more details please visit us.



    Global Cardiopulmonary Exercise Testing Market Poised to Witness at a 5.80% CAGR from 2018 to 2023: Pune, India, November 2018/MRFR Press Release/- Market Research Future has published a cooked research report on the Global Cardiopulmonary Exercise Testing Market.

    The latest report published by Market Research Future (MRFR) projects that the global market for cardiopulmonary exercise testing will exhibit a CAGR of 5.80% during the review period (2018-2023). Cardiopulmonary exercise testing is conducted to assess the health of cardiopulmonary organs of a person. It allows physicians to accurately measure the exercise capacity and anticipated outcome in patient with heart ailments or any other cardiac condition. In addition, such tests allow evaluation of responses from integrative exercise for patients having cardiovascular and pulmonary issues.

    Global Cardiopulmonary Exercise Testing Market: Competitive Landscape

    MGC Diagnostics Corporation, GE Healthcare, COSMED srl, Hill-Rom Holdings, Inc., Cardinal Health, Vyaire Medical, Inc., Halma plc., Masimo Corporation, Schiller AG, Koninklijke Philips N.V., and NIHON KOHDEN CORPORATION are some of notable companies that are currently operating in the global cardiopulmonary exercise testing market.

    Get Sample Copy for this Report at

    Global Cardiopulmonary Exercise Testing Market: Segmental Analysis

    MRFR’s report includes a comprehensive segmental analysis of the market based on products and end-user. On the basis of product, the market has been segmented into cardiopulmonary exercise testing (CPET) systems, echocardiogram, pulse oximeters, stress blood pressure monitors, single-photon emission computed tomography (SPECT), and others. Of these, the cardiopulmonary exercise testing systems segment is expected to post a health growth rate over in the years to come. The segment currently accounts for the largest share of the market. This is attributed to the increasing incidence of ischemia. Moreover, cardiopulmonary exercise testing systems are a common medical equipment and continue to witness high demand in the healthcare sector.

    On the basis of end-user, the global cardiopulmonary exercise testing market is segmented into hospitals and clinics, diagnostic centers, ambulatory centers, and others. The hospitals and clinics segment is currently holds the top position. The segment is projected to reach a market valuation of over USD 1100 Mn by the year 2023, reflecting an impressive growth rate. Growing need for diagnosis and treatment of heart diseases and coronary diseases is supporting the growth of the segment.

    Other Description

    Market Denomination- USD Mn
    Base Year- 2017
    Forecast Period- from 2018 to 2023
    Browse Complete Premium Research Report Enabled with Respective Tables and Figures at

    About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

    In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


    Office No. 528, Amanora Chambers

    Magarpatta Road, Hadapsar, Pune

    +1 646 845 9312


Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.